IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Novel HIV vaccine candidate stimulates immune response in T cells

May 25, 2023

New analysis of IAVI G001 trial shows nanoparticle HIV vaccine creates strong immune response in helper T cells

Read more

Scientific Publications

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

Read more

IAVI Report

COVID-19 is no longer an emergency, but its lessons better linger

May 24, 2023

Two new books illustrate why reflection and preparation are both essential to ensure a quicker and more equitable response to the next pandemic.

Read more

Scientific Publications

Antibodies for HIV prevention: the path forward

Read more

Press Releases

Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

May 16, 2023

TB kills 1.6 million people a year, causing more deaths than any other single infectious disease apart from COVID-19, and sickens more than 10 million people annually. A new TB vaccine is needed to reach global END TB goals. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an…

Read more

Features

New IAVI paper makes the case for strengthening clinical and regulatory pathways to accelerate global access to monoclonal antibodies

May 10, 2023

Expanded access would benefit many in low- and middle-income countries.

Read more

IAVI Report

Keeping it all in perspective

May 9, 2023

A view from Zambia on the shifting landscape of HIV vaccine research and the enduring optimism that characterizes one researcher’s drive.

Read more

Scientific Publications

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond

Read more